FDA Approves Vimseltinib for Symptomatic Tenosynovial Giant Cell Tumour By Ogkologos - April 4, 2025 595 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the MOTION study Source RELATED ARTICLESMORE FROM AUTHOR Noninferiority of OS with 3 Months Compared to 6 Months of Adjuvant Chemotherapy for Patients with High-Risk Stage III Colorectal Cancer Patient Guide on Bone Health in Cancer Now Available Also in French Lung Cancer Death Rates Among Women in Europe Are Finally Levelling Off MOST POPULAR pCR Associated with Improved Survival Outcomes in Patients with Soft Tissue... April 3, 2023 27-Year-Old Fighting Stage IV Cancer Gets Hit By COVID-19 And Sepsis... May 29, 2020 Early-Stage and Locally Advanced NSCLC: ESMO Clinical Practice Guideline August 28, 2025 Aspirin Being Investigated as Possible Treatment for Triple Negative Breast Cancer August 21, 2021 Load more HOT NEWS Engaging People with Low-Grade Glioma in Cancer Research Diagnosed 3 Weeks Before Her Wedding, She Finally Gets To Ring... ΚΑΡΚΙΝΟΣ ΩΟΘΗΚΩΝ Giving Myself the Most Time and Best Chance at Beating Cancer:...
